Steven Cohen Macrogenics Inc Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $2,602 - $3,909	540 New	540 $3,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $10.2 Million - $21.3 Million	-1,260,161 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.91 - $21.88 $5.99 Million - $8.24 Million	376,700 Added 42.64%	1,260,161 $20.2 Million
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $9.28 Million - $13.5 Million	470,361 Added 113.86%	883,461 $18.5 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $3.37 Million - $5.86 Million	-164,600 Reduced 28.49%	413,100 $11.1 Million
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $16.8 Million - $29.3 Million	-882,433 Reduced 60.44%	577,700 $18.4 Million
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $41.4 Million - $55.5 Million	-2,134,946 Reduced 59.39%	1,460,133 $33.4 Million
Q3 2020 Nov 16, 2020	BUY	$24.69 - $31.6 $55.2 Million - $70.6 Million	2,234,949 Added 164.32%	3,595,079 $90.6 Million
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $6.15 Million - $34.5 Million	1,183,067 Added 668.16%	1,360,130 $38 Million
Q1 2020 May 15, 2020	BUY	$4.28 - $12.11 $757,829 - $2.14 Million	177,063 New	177,063 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$7.95 - $12.27 $2.9 Million - $4.48 Million	-364,889 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$12.44 - $17.48 $1 Million - $1.41 Million	-80,683 Reduced 18.11%	364,889 $4.66 Million
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $16 Million - $21.8 Million	-1,105,677 Reduced 71.28%	445,572 $7.56 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $11.8 Million - $27.2 Million	1,064,009 Added 218.37%	1,551,249 $27.9 Million
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $7.6 Million - $13.9 Million	-647,177 Reduced 57.05%	487,240 $6.19 Million
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $963,000 - $1.17 Million	50,000 Added 4.61%	1,134,417 $24.3 Million
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $1.57 Million - $1.97 Million	-96,900 Reduced 8.2%	1,084,417 $20.6 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $18.3 Million - $22.4 Million	1,181,317	1,181,317 $21.8 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.2 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.3 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.1 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account